Kommer oor herroepte gewigsverlies medisyne

Nuus

Suid-Afrika se gesondheidsreguleerders waarsku die publiek en gesondheidsorgpersoneel om nie herroepte iDEXIS Semaglutide- en Tirzepatide-medisyne te gebruik, voor te skryf of uit te reik nie. Die reg...

This preview comes from the publisher’s feed. Read the complete story at the original source, or explore more articles from this feed below.

Read the original at iono.fm

Use this feed in your RSS reader

Copy the publisher’s public feed URL, or build an OPML reading list for another reader.

Open RSS feed · Find feeds & export OPML

Keep up with this source

Keep this source in your dashboard and return to its latest articles. Email alerts are managed separately in Settings.

FetchFeeds groups articles by feed so you can follow sources, compare coverage, and save stories for later.

Back to all articles from Nuus

Kommer oor herroepte gewigsverlies medisyne

Nuus

Use this feed in your RSS reader

Keep up with this source

More from this feed